Skip to main content
. 2017 Apr 11;8(34):56518–56532. doi: 10.18632/oncotarget.17033

Table 1. Candidate miRNAs from microarray analysis of NB cell lines.

miRNA ALK- group ALK+ group rawp-value Fold change
hsa-miR-526b-3p 1.92 0.27 0.042 3.14
hsa-miR-424-5p 8.02 6.72 0.008 2.48
hsa-miR-520e 2.86 2.13 0.032 1.65
hsa-miR-100-5p 7.87 3.59 0.019 19.45
hsa-miR-29b-3p 8.17 4.12 0.04 16.65
hsa-miR-29a-3p 9.48 5.46 0.009 16.20
hsa-miR-503-5p 5.68 2.95 0.022 6.65
hsa-miR-221-3p 5.56 2.88 0.015 6.41
hsa-miR-21-5p 11.31 8.73 0.002 5.98
hsa-miR-22-3p 7.82 5.60 0.007 4.67
hsa-miR-29b-1-5p 4.13 2.64 0.014 2.81
hsa-miR-23a-3p 7.93 6.68 0.016 2.37

The table reports data only for miRNAs selected for validation analysis. Expression values reported in the ALK+ and ALK- columns were log2-transformed and normalized.